MedTrace Logo

Hydroxyethyl Starch and Renal Function After Laparoscopic Nephrectomy

NCT01486550 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2014-10-09

No results posted yet for this study

Summary

The purpose of this project is to investigate if hydroxyethyl starch (HES) is potential nephrotoxic and examine the effects on the circulation and kidneys during administration of HES during surgery.

Conditions

Interventions

DRUG

Voluven (Hydroxyethyl starch 130/0,4)

7,5 ml/kg in the first hour and then 5 ml/kg minimum

DRUG

Sodium Chloride 9mg/ml

7,5 ml/kg in the first hour and then 5 ml/kg

Sponsors & Collaborators

  • Regional Hospital Holstebro

    lead OTHER

Principal Investigators

  • Anne Sophie P. Kancir, MD PhD · Regional Hospital Holstebro

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-12-31
Primary Completion
2014-09-30
Completion
2014-09-30

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01486550 on ClinicalTrials.gov